Chubby♨️@kimmonismus · X56
AI 摘要
全球已有超过200款AI设计的药物进入临床试验。但尚无一款获得FDA批准。 FDA刚刚启动了一项试点计划，以研究应如何评估药物申报中AI生成的证据，并选择了10家公司进行加速、互动的审评流程。 药物研发跑在了监管框架前面。这才是AI制药领域的现状。
Over 200 AI-designed drugs are now in clinical trials worldwide. Not a single one has been FDA-approved.
The FDA just launched a pilot program to work out how it should even evaluate AI-generated evidence in drug submissions， selecting 10 companies for an expedited， interactive review process.
The drugs got ahead of the regulatory framework. That's the actual state of AI pharma right now.